Limits...
An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain.

Cuomo RE, Mackey TK - BMJ Open (2014)

Bottom Line: These data were used to generate the overarching study outcome, which was a recommendation for a strategy for drug safety surveillance congruent with existing literature on counterfeit medication.Importantly, the information generated by these analyses could be utilised to identify at-risk populations associated with demographic characteristics.Stakeholders should explore these results as another tool to improve on counterfeit medicine surveillance.

View Article: PubMed Central - PubMed

Affiliation: Global Health Policy Institute, La Jolla, California, USA Joint Doctoral Program in Global Public Health, University of California, San Diego-San Diego State University, San Diego, California, USA.

Show MeSH

Related in: MedlinePlus

Choropleth maps of the USA comparing counties with greater than 2500 multiracial individuals with (A) Wave 1 notices and (B) Wave 2 notices.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4256545&req=5

BMJOPEN2014006657F5: Choropleth maps of the USA comparing counties with greater than 2500 multiracial individuals with (A) Wave 1 notices and (B) Wave 2 notices.

Mentions: When examining in more detail the differences between waves 1 and 2, t tests revealed four variables with significantly different means in wave 1 zip codes compared to means in wave 2 zip codes (table 2). Three of these variables pertained to race. Maps comparing counties with high numbers of multiracial individuals (above 2500 people) with the distributions of waves 1 and 2 notices revealed that many of these counties were in Southern California (figure 5), which is the same region where wave 1 notices were found to be concentrated in point density maps (figure 3A).


An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain.

Cuomo RE, Mackey TK - BMJ Open (2014)

Choropleth maps of the USA comparing counties with greater than 2500 multiracial individuals with (A) Wave 1 notices and (B) Wave 2 notices.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4256545&req=5

BMJOPEN2014006657F5: Choropleth maps of the USA comparing counties with greater than 2500 multiracial individuals with (A) Wave 1 notices and (B) Wave 2 notices.
Mentions: When examining in more detail the differences between waves 1 and 2, t tests revealed four variables with significantly different means in wave 1 zip codes compared to means in wave 2 zip codes (table 2). Three of these variables pertained to race. Maps comparing counties with high numbers of multiracial individuals (above 2500 people) with the distributions of waves 1 and 2 notices revealed that many of these counties were in Southern California (figure 5), which is the same region where wave 1 notices were found to be concentrated in point density maps (figure 3A).

Bottom Line: These data were used to generate the overarching study outcome, which was a recommendation for a strategy for drug safety surveillance congruent with existing literature on counterfeit medication.Importantly, the information generated by these analyses could be utilised to identify at-risk populations associated with demographic characteristics.Stakeholders should explore these results as another tool to improve on counterfeit medicine surveillance.

View Article: PubMed Central - PubMed

Affiliation: Global Health Policy Institute, La Jolla, California, USA Joint Doctoral Program in Global Public Health, University of California, San Diego-San Diego State University, San Diego, California, USA.

Show MeSH
Related in: MedlinePlus